These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20806111)

  • 1. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
    Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
    Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
    Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
    Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
    J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
    Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
    Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA).
    Attanasio C; David A; Neerman-Arbez M
    Blood; 2003 Mar; 101(5):1851-6. PubMed ID: 12406899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
    Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
    Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fibrinogen B beta chain frameshift mutation causes congenital afibrinogenaemia.
    Zhang J; Zhao X; Wang Z; Yu Z; Cao L; Zhang W; Bai X; Ruan C
    Thromb Haemost; 2013 Jul; 110(1):76-82. PubMed ID: 23740095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
    Spena S; Duga S; Asselta R; Malcovati M; Peyvandi F; Tenchini ML
    Blood; 2002 Dec; 100(13):4478-84. PubMed ID: 12393540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
    Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
    Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
    Asselta R; Robusto M; Braidotti P; Peyvandi F; Nastasio S; D'Antiga L; Perisic VN; Maggiore G; Caccia S; Duga S
    J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze).
    Undas A; Pastuszczak M; Iwaniec T; Kapelak K; Neerman-Arbez M
    Thromb Haemost; 2010 Aug; 104(2):415-7. PubMed ID: 20508898
    [No Abstract]   [Full Text] [Related]  

  • 18. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
    Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
    J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
    Castaman G; Giacomelli SH; Duga S; Rodeghiero F
    Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.